scholarly article | Q13442814 |
P2093 | author name string | Furukawa T | |
Honjo T | |||
Sakai T | |||
Bornkamm GW | |||
Hinrichs R | |||
Strobl LJ | |||
Zimber-Strobl U | |||
Meitinger C | |||
P2860 | cites work | erg, an ets-related gene, codes for sequence-specific transcriptional activators | Q28238746 |
A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif | Q28255047 | ||
NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif | Q30990862 | ||
cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. | Q31117684 | ||
Genomic organization of mouse J kappa recombination signal binding protein (RBP-J kappa) gene | Q33280885 | ||
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element | Q33810690 | ||
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor | Q33856709 | ||
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. | Q34245077 | ||
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter | Q34355226 | ||
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells | Q34366291 | ||
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. | Q34625121 | ||
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein | Q36581891 | ||
The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor | Q36652805 | ||
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus | Q36688330 | ||
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation | Q36689004 | ||
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter | Q36697355 | ||
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus | Q36791391 | ||
Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element | Q36797190 | ||
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. | Q36801839 | ||
The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization | Q36806641 | ||
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression | Q36828413 | ||
Recognition sequence of a highly conserved DNA binding protein RBP-J kappa | Q38309890 | ||
A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway | Q38340261 | ||
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas | Q40259681 | ||
Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment | Q40539051 | ||
The B cell-immortalizing functions of Epstein-Barr virus | Q40717683 | ||
The Ets family of transcription factors | Q40871575 | ||
Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence | Q41099910 | ||
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE | Q41210330 | ||
Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates | Q43575150 | ||
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization | Q45845786 | ||
The Drosophila homolog of the immunoglobulin recombination signal-binding protein regulates peripheral nervous system development. | Q52444074 | ||
Magnetic DNA affinity purification of yeast transcription factor | Q70758996 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Epstein–Barr virus | Q6900 |
Drosophila | Q312154 | ||
P304 | page(s) | 4973-4982 | |
P577 | publication date | 1994-10-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless | |
P478 | volume | 13 |
Q24682619 | A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa |
Q39736828 | A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. |
Q24524363 | A role for SKIP in EBNA2 activation of CBF1-repressed promoters |
Q33884014 | A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent |
Q36315750 | Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells |
Q33850400 | Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells |
Q33797347 | Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. |
Q39549769 | Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters |
Q40423684 | Activation of the Notch-regulated transcription factor CBF1/RBP-Jkappa through the 13SE1A oncoprotein |
Q39642344 | An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter |
Q36845680 | Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection |
Q31081505 | Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression |
Q22008610 | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex |
Q40883667 | CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation |
Q39876911 | Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP |
Q22010174 | Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C |
Q38341023 | Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. |
Q34049435 | Clustered LAG-1 binding sites in lag-1/CSL are involved in regulating lag-1 expression during lin-12/Notch-dependent cell-fate specification |
Q40088750 | Coordinate Regulation of TET2 and EBNA2 Control DNA Methylation State of Latent Epstein-Barr Virus |
Q38966100 | Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions |
Q36236802 | Crosstalk between Nrf2 and Notch signaling. |
Q36061599 | Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. |
Q34234140 | Cytokine signaling and Epstein-Barr virus-mediated cell transformation |
Q35941628 | Deregulation of the cell cycle by the Epstein-Barr virus |
Q39776571 | Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. |
Q35732134 | Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation |
Q37596770 | Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus |
Q41926654 | EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. |
Q35862488 | EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes |
Q37093792 | EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance |
Q24679432 | EBNA2 and Activated Notch Induce Expression of BATF |
Q38597233 | EBNA2 and Its Coactivator EBNA-LP. |
Q57186827 | EBNA2: A Viral Transcription Factor Essential for the Immortalization of Human B Lymphocytes by the Epstein-Barr Virus (EBV) |
Q35889902 | EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells |
Q42487093 | EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. |
Q47117102 | EBV and Apoptosis: The Viral Master Regulator of Cell Fate? |
Q57186814 | EBV genes and B cell proliferation |
Q58746075 | Enhancer control of miR-155 expression in Epstein-Barr virus infected B cells |
Q60920702 | Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle? |
Q58803477 | Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis |
Q24530175 | Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC |
Q39306073 | Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter. |
Q38353695 | Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. |
Q39882226 | Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. |
Q24678677 | Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation |
Q35917481 | Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. |
Q40541072 | Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen |
Q33887684 | Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade |
Q35891377 | Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain |
Q41063703 | Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. |
Q24537547 | Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. |
Q39594681 | Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription |
Q34782258 | Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines |
Q39607885 | Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation |
Q24681418 | Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1 |
Q33850964 | Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association |
Q35839108 | Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa |
Q35891360 | Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation |
Q33888498 | Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor |
Q39594354 | Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression. |
Q38295122 | Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter |
Q39582561 | Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. |
Q32151473 | Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen |
Q34160976 | Immortalization of human primary B lymphocytes in vitro with DNA |
Q37358334 | Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide |
Q39588351 | Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells |
Q39631445 | LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein |
Q24682515 | Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway |
Q64990535 | Manipulation of Epithelial Differentiation by HPV Oncoproteins. |
Q39585366 | Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation |
Q28117643 | Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha |
Q34225554 | Molecular virology of Epstein-Barr virus |
Q22254088 | NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells |
Q39631069 | NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa |
Q34069973 | Notch signaling functions in retinal pericyte survival |
Q37546854 | Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling. |
Q28594415 | Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells |
Q33842309 | Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus |
Q41352439 | Oncoprotein networks |
Q28286560 | Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H) |
Q33604108 | Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. |
Q40397055 | RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. |
Q28508784 | RBP-L, a transcription factor related to RBP-Jkappa |
Q38793717 | RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. |
Q35101899 | Regulation of B cell development by Notch/RBP-J signaling |
Q36845685 | Role of AID in tumorigenesis |
Q37093324 | Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells |
Q33795078 | Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses |
Q52205935 | Signal transduction. Notch takes a short cut. |
Q28289832 | Signalling downstream of activated mammalian Notch |
Q33643991 | Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure |
Q27682610 | Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIH |
Q30090224 | Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations |
Q40984279 | Suppressor of Hairless is required for signal reception during lateral inhibition in the Drosophila pupal notum |
Q41244135 | TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers. |
Q34341875 | The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance |
Q42702063 | The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter |
Q33787243 | The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5 |
Q36445900 | The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis |
Q38660700 | The N- and C-terminal regions of RBP-J interact with the ankyrin repeats of Notch1 RAMIC to activate transcription |
Q38301679 | The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. |
Q40758890 | The amino acid region 248-382 of the Epstein-Barr virus nuclear protein 2 (EBNA2) is responsible for the EBNA2-induced EBV reactivation |
Q24310605 | The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa) |
Q24291962 | The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif |
Q37325443 | The curious case of the tumour virus: 50 years of Burkitt's lymphoma |
Q33845947 | The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters |
Q36564525 | The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression |
Q35201509 | The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription |
Q28201623 | The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity |
Q39755299 | The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene |
Q39551287 | The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. |
Q48143289 | Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL. |
Q52319664 | Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. |
Q35861192 | Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells |
Q36555784 | Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. |
Q24650743 | Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 |
Q37785198 | Two Opposing Roles of RBP-J in Notch Signaling |
Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
Q36559612 | Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains |
Q37340989 | c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. |
Search more.